Woebot Health

535 Mission Street, 14th Floor, San Francisco, CA 94105, United States  All United States companies → Founded 2017
Mental Health Platform
Family Medicine Internal Medicine Psychiatry
Patient Engagement & Education
Series B — $129M

Products

Woebot for Adults
Woebot Health
Patient Engagement & Education
Woebot for Adults is an AI chatbot offering CBT-based support and collecting patient-reported outcomes, designed as an adjunctive tool for clinicians to enhance mental healthcare accessibility.

See all 1 product →

About Woebot Health

Woebot Health is a pioneering AI-powered digital therapeutics company committed to enhancing the accessibility and effectiveness of mental healthcare. Established in 2017, the company utilizes its proprietary relational agent, Woebot, to deliver engaging and evidence-based therapeutic solutions. Woebot is designed to quickly establish a therapeutic bond with users, providing human-like conversational support that is psychologically relevant and responsive to an individual’s evolving mental health state.

The platform integrates natural language processing with clinically validated therapeutic techniques, including Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT). This approach offers personalized support and guidance for a range of mental health challenges such as depression, anxiety, and stress. Woebot Health aims to address critical gaps in traditional mental healthcare by offering 24/7 access to support, collecting patient-reported outcomes (PRO data), and seamlessly integrating within existing health ecosystems to augment clinician efforts without increasing their burden. The company is also actively exploring advancements in AI and machine learning, including large language models (LLMs), for future product development.

Focus Areas

Digital therapeutics mental health AI-powered chatbot anxiety depression postpartum depression substance use disorder Cognitive Behavioral Therapy (CBT) Natural Language Processing (NLP) relational agent technology

Business Intelligence

Key InvestorsJAZZ Venture Partners, Temasek, BlackRock Private Equity Partners, Owl Ventures, Mirae Asset Capital, Kicker Ventures, Alumni Ventures, Gaingels, NEA, AI Fund, Leaps by Bayer, Chestnut Street Ventures, Half Court Ventures, Keybridge Venture Partners, Goodwater Capital
PartnershipsAkron Children's Hospital, Virtua Health, PayrollPlans, Curai Health
TechnologyAI-powered relational agent, natural language processing (NLP), evidence-based therapeutic techniques (Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Dialectical Behavior Therapy), conversational AI platform, research into Large Language Models (LLMs)

What Physicians Need to Know

Digital Therapeutics & Mental Health Focus
Woebot Health specializes in AI-powered digital therapeutics for mental health, addressing conditions like anxiety, depression, postpartum depression, and substance use disorder.
Relational Agent Technology
Their proprietary 'relational agent,' Woebot, is designed to quickly form a therapeutic bond with users, delivering human-like therapeutic encounters. This bond has been shown to be comparable to that achieved by human therapists and can be established rapidly.
Evidence-Based & Clinically Validated
Woebot Health is a leader in peer-reviewed scientific literature among digital therapeutics companies, with 14 randomized controlled trials (RCTs) demonstrating efficacy in reducing symptoms of depression, anxiety, and problematic substance use.
Ethical AI & Human-Centered Design
Conversations are crafted by conversational writers with training in evidence-based approaches like CBT, IPT, and DBT, in collaboration with clinical experts. AI primarily focuses on understanding user intent and routing to human-composed content, with a strong emphasis on safety, privacy (HIPAA compliant), and ethical frameworks.
Scalable & Accessible Support
The platform provides 24/7 chat-based support, making mental health care more accessible and scalable, helping to close gaps in care and reduce clinician burden.
Enterprise-Focused Model
Woebot Health operates on an enterprise model, partnering with payers, providers, and businesses to integrate its solutions into existing healthcare ecosystems.
Technology Stack
The core technology involves an AI-powered platform leveraging Natural Language Processing (NLP) to interpret user inputs and personalize the experience. While exploring Large Language Models (LLMs) for future enhancements, current user-facing content is human-generated and reviewed.
Physician Tip

For physicians, Woebot Health offers a valuable adjunctive tool to extend care beyond traditional settings, without increasing clinician burden. It automatically collects patient-reported outcomes (PROs) using validated scales, which can support value-based care initiatives and reimbursement. The platform's strong clinical validation and ethical AI approach provide confidence in its effectiveness and safety, while also offering population health insights. It can help address access gaps for patients, particularly in underserved populations.

Woebot Health's platform is designed for seamless integration into existing health ecosystems. It offers an extensive Application Programming Interface (API) library to integrate with partners' digital front doors, Electronic Medical Records (EMRs), and existing care pathways.

Products by Woebot Health

1 product in the directory

Woebot for Adults
Woebot Health
Patient Engagement & Education
Woebot for Adults is an AI chatbot offering CBT-based support and collecting patient-reported outcomes, designed as an adjunctive tool for clinicians to enhance mental healthcare accessibility.

What the Web Says

Woebot Health provides an AI-driven mental health chatbot that offers real-time, chat-based support using evidence-based techniques like Cognitive Behavioral Therapy (CBT), Interpersonal Psychotherapy (IPT), and Dialectical Behavioral Therapy (DBT). While the consumer-facing app was discontinued in June 2025 due to a strategic shift towards enterprise solutions, it was highly regarded for its clinical rigor and effectiveness in reducing symptoms of depression and anxiety. The platform is now primarily aimed at healthcare organizations, payers, and employers to scale mental health support and integrate AI-driven interventions into existing care pathways.

Overall: Positive

Strengths

  • Immediate and 24/7 accessible mental health support.
  • Utilizes evidence-based techniques like CBT, IPT, and DBT.
  • Clinically validated with multiple randomized controlled trials showing significant reductions in depression and anxiety symptoms.
  • Scalable to reach a large user base and provides data-driven insights for healthcare providers.
  • Offers personalized support and engaging, user-friendly tools.
  • Complies with HIPAA standards for user privacy and data security.

Limitations

  • Limited to chat-based interactions, which may not suit everyone.
  • May not address deeper or more serious mental health issues, serving as a complement rather than a replacement for traditional therapy.
  • Some users found the rules-based system to feel scripted and lacking in genuine conversational ability.
  • The consumer app was shut down in June 2025, limiting direct access for individuals.
  • Can sometimes flag sentences as dangerous incorrectly, interrupting the flow of conversation.
  • Relies on user accountability for completing exercises and may not track if tasks are taken seriously.

Based on reviews from: Futurepedia, Woebot Health Digital Therapeutics Platform Honest Review - Watch Before Using, Clinical AI Report, Elion, Unwanted Life, Reddit, Business Insider, App Store - Apple, Vocalime, Family Service of Roanoke Valley, Could The Woebot App Replace Your Therapist?, Best AI Therapy, CompareThe.AI

Last updated: 2026-07-22

Videos

News, demos, and interviews about Woebot Health.

Loading videos...

Videos load interactively. If none appear, search YouTube for Woebot Health →

View all on YouTube

Press & Coverage

HLTH
Woebot Health Is Shutting Down Its App - HLTH
Woebot Health announced it would retire its consumer-facing app on June 30, 2025, to strategically refocus on enterprise, payer, and health-system licensing. The company's nonprescription digital mental health tool included specialized content for teens.
2025-04
Woebot Health
Woebot Health Wins MedTech Breakthrough's Mental Health Innovation Award
Woebot Health received the u201cMental Health Innovation Awardu201d in the 8th annual MedTech Breakthrough Awards program. This award recognizes the company's innovative digital solutions for mental health.
2024-05
CBS News
Can AI help fill the therapist shortage? Mental health apps show promise and pitfalls
Woebot Health's AI-powered chatbot, Woebot, is highlighted as a tool to address the therapist shortage, offering support when human therapists are unavailable. The article discusses both the promise and potential pitfalls of AI in mental health.
2024-04
Regulations.gov
October 31, 2024 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 - Regulations.gov
Woebot Health submitted comments to the FDA's Digital Health Advisory Committee regarding lifecycle considerations for generative AI in medical devices. The company emphasized a 'human in the loop' approach and a risk-based regulatory review.
2024-10
Woebot Health
New Woebot Health Study Highlights AI's Ability to Address Equity and Accessibility Gaps in Mental Health Care
A new study by Woebot Health demonstrated that Woebot for Adults helped reduce symptoms of depression and anxiety, improved wellness outcomes, and had high engagement across diverse participant groups, addressing equity and accessibility gaps in mental healthcare.
2023-08
Woebot Health
Woebot Health Secures $9.5 Million Investment From Leaps by Bayer
Leaps by Bayer, the impact investment arm of Bayer AG, made a $9.5 million strategic investment in Woebot Health to accelerate the development of its AI-powered behavioral health platform. This brings Woebot Health's total investment to $123.5 million.
2022-03
Woebot Health
Woebot Health Closes $90 Million Series B Funding Round Co-Led by JAZZ Venture Partners and Temasek
Woebot Health closed a $90 million Series B funding round, co-led by JAZZ Venture Partners and Temasek, bringing the total investment in the company to $114 million. This funding followed the FDA Breakthrough Device designation for its postpartum depression digital therapeutic.
2021-07
Journal of Medical Internet Research (JMIR)
A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study - PMC
This study published in JMIR explored the adaptation of Woebot for substance use disorders (W-SUDs) and examined its feasibility, acceptability, and preliminary efficacy. It found significant reductions in substance use and cravings.
2021-03

Frequently Asked Questions

Woebot Health offers digital mental health support for conditions such as anxiety, depression, postpartum depression (PPD), and problematic substance use. Their AI-powered chatbot utilizes evidence-based approaches like Cognitive Behavioral Therapy (CBT), Interpersonal Psychotherapy (IPT), and Dialectical Behavioral Therapy (DBT).
Woebot Health's platform uses Natural Language Processing (NLP) and relational agent technology to engage users in therapeutic conversations, aiming to form a bond similar to human-to-human interactions. Clinical trials, including randomized controlled trials (RCTs), have demonstrated its efficacy in reducing symptoms of depression, anxiety, and problematic substance use, with studies showing comparable therapeutic bond formation to human therapists.
Woebot Health's investigational digital therapeutic for postpartum depression (WB001) has received FDA Breakthrough Device Designation, with ongoing pivotal clinical trials for potential FDA clearance. Other products like 'Woebot for Adults' are non-prescription digital mental health support tools and are not FDA-cleared. The company treats all user data as Protected Health Information (PHI) and adheres to HIPAA and GDPR requirements, employing hospital-level security policies, data encryption, and regular external assessments.
Woebot Health's platform is designed to integrate into existing care pathways and electronic medical records (EMRs), providing adjunctive support outside traditional clinic settings. They offer customized clinician enablement programs, shared resource centers for training and deployment, and collect patient-reported outcomes (PROs) to support value-based care initiatives and provide population insights.
While specific pricing models are not publicly detailed, Woebot Health works with payers, health systems, and virtual primary care companies, suggesting enterprise-level agreements. Reimbursement for digital therapeutics is an evolving area, and Woebot Health is actively involved in industry efforts, including the Digital Therapeutics Alliance, to establish and advance reimbursement pathways.
Woebot Health has established partnerships with healthcare systems like Virtua Health and Akron Children's, as well as collaborations with companies like Bayer AG and PayrollPlans, to expand access to mental health support. The company has secured significant funding, totaling over $123 million, from various investors, including major Series B funding, demonstrating strong investor confidence and financial stability.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare fintech company that leverages AI and automation to address the growing challenge of healthcare affordability for patients and financial stability for providers. The platform offers personalized, interest-free payment plans, extending up to 60 months, tailored to each patient’s ability to pay. This approach aims to remove financial barriers to care, allowing […]

Healthcare Finance.AI is dedicated to optimizing healthcare revenue cycles through cutting-edge AI technologies. The company aims to improve financial outcomes for healthcare providers while supporting their commitment to quality care and efficiency. Their solutions are designed to enhance revenue cycle efficiency, reduce claim turnaround times, and improve patient billing accuracy. Their platform leverages advanced analytics […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School, a faculty of Imperial College London, is a leading institution that integrates business education with science, engineering, medicine, and technology. For physicians and healthcare providers, the Business School offers specialized programs and research focused on the intersection of AI, digital transformation, and healthcare management. Their curriculum is designed to equip healthcare […]

Columbia University, through its online learning platform edX, offers a range of educational programs, including those focused on artificial intelligence and its applications in healthcare. While not a direct AI product company, Columbia University provides foundational and advanced courses that equip physicians and healthcare providers with the knowledge and skills to understand, evaluate, and potentially […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.